Skip to content
Home/Companies/Biotech/General Biotechnologies

General Biotechnologies

Biotech·United Kingdom·Active·New
Entry
2026
Hold
New
Status
Active

Who owns General Biotechnologies?

General Biotechnologies is a British Biotech company, currently owned by Kompas Vc since 2026.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
Kompas Vc
Investor
Kompas Vc
Kompas Fund II · 2025 · VC

Key facts

HQUnited Kingdom
SectorBiotech
StatusActive

More from Kompas Fund II

Other portfolio companies in the same fund.

Array Labs
Array Labs
Active
Aerospace & DefenceUS· 2026
AZX
Active
AI/MLUS· 2026
Backslash
Active
CybersecurityIsrael· 2026
Epoch Biodesign
Active
ClimateTechUK· 2026
Timefold
Timefold
Active
SaaSBelgium· 2026
United Manufacturing Hub
Active
IndustrialsGermany· 2026

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns General Biotechnologies?

General Biotechnologies is currently owned by Kompas Vc, through Kompas Fund II, since 2026.

When did Kompas Vc acquire General Biotechnologies?

Kompas Vc acquired General Biotechnologies in 2026.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue